This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Change to scalable lot sizes in the component manufacturing process of elecsys® anti-hcv immunoassay and elecsys® precicontrol anti-hcv and a change in the lyophilisation process.
| Device | ELECSYS ANTI-HCV IMMUNOASSAY ON MUDULAR ANALYTICS |
| Classification Name | Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus |
| Generic Name | Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus |
| Applicant | ROCHE DIAGNOSTICS CORP. |
| Date Received | 2011-11-21 |
| Decision Date | 2011-12-14 |
| PMA | P090009 |
| Supplement | S006 |
| Product Code | MZO |
| Advisory Committee | Microbiology |
| Supplement Type | 30-day Notice |
| Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | ROCHE DIAGNOSTICS CORP. 9115 Hague Rd. indianapolis, IN 46250 |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P090009 | Original Filing | |
| S018 | 2018-10-26 | Normal 180 Day Track No User Fee |
| S017 | 2017-10-11 | Real-time Process |
| S016 | 2017-08-03 | 30-day Notice |
| S015 | 2016-02-16 | 30-day Notice |
| S014 | 2016-01-27 | 30-day Notice |
| S013 | 2015-10-07 | 30-day Notice |
| S012 | 2014-08-22 | 30-day Notice |
| S011 | 2012-11-30 | 30-day Notice |
| S010 | 2012-09-05 | 30-day Notice |
| S009 | ||
| S008 | 2012-02-29 | 30-day Notice |
| S007 | 2012-01-31 | 135 Review Track For 30-day Notice |
| S006 | 2011-11-21 | 30-day Notice |
| S005 | 2011-08-29 | 135 Review Track For 30-day Notice |
| S004 | 2011-08-17 | 135 Review Track For 30-day Notice |
| S003 | 2011-05-17 | Normal 180 Day Track No User Fee |
| S002 | 2011-04-11 | 30-day Notice |
| S001 | 2010-07-28 | Normal 180 Day Track |